Very old cardiac patients (≥75 years) undergoing cardiac rehabilitation had a significantly higher death rate during the programs compared to younger patients (OR 4.6; 95% CI 1.6-12.9; p=0.004).
Observational (n=2,281)
Yes
What are the characteristics and outcomes of very old cardiac patients participating in cardiac rehabilitation programs compared to younger patients?
Very old patients referred to cardiac rehabilitation have more comorbidities, are more often referred after surgery or acute heart failure, and have a higher mortality rate during the program compared to younger patients.
Effect estimate: OR 4.6 (95% CI 1.6-12.9)
p-value: p=.004
BACKGROUND: Using data from the Italian SurveY on carDiac rEhabilitation-2008 (ISYDE-2008), this study provides insight into the level of implementation of cardiac rehabilitation (CR) in very old cardiac patients. METHODS: Data from 165 CR units were collected online from January 28 to February 10, 2008. RESULTS: The study cohort consisted of 2,281 patients (66.9 ± 11.8 years): 1,714 (62.4 ± 9.6 years, 78% male) aged<75 years and 567 aged ≥ 75 years (80.8 ± 4.5 years, 59% male). Compared with adults, a higher percentage of older patients were referred to CR programs after cardiac surgery or acute heart failure and showed more acute phase complications and comorbidity. Older patients were less likely discharged to home, more likely transferred to nursing homes, or discharged with social networks activation. Older patients had higher death rate during CR programs (odds ratio = 4.6; 95% confidence interval = 1.6-12.9; p = .004). CONCLUSION: The ISYDE-2008 survey provided a detailed snapshot of CR in very old cardiac patients.
Giallauria et al. (Wed,) conducted a observational in Cardiac disease requiring rehabilitation (n=2,281). Cardiac rehabilitation in patients ≥75 years vs. Cardiac rehabilitation in patients <75 years was evaluated on Death rate during CR programs (OR 4.6, 95% CI 1.6-12.9, p=.004). Very old cardiac patients (≥75 years) undergoing cardiac rehabilitation had a significantly higher death rate during the programs compared to younger patients (OR 4.6; 95% CI 1.6-12.9; p=0.004).